Hearing on "The Overdose Crisis: Interagency Proposal to Combat Illicit Fentanyl-Related Substances"
The Subcommittee on Health of the Committee on Energy and Commerce held a hybrid hearing that included both in-person and remote attendance on Thursday, December 2, 2021, at 10:30 a.m. This hearing took place in the John D. Dingell Room, 2123 of the Rayburn House Office Building, as well as remotely using Cisco Webex online video conferencing. The hearing is entitled, "The Overdose Crisis: Interagency Proposal to Combat Illicit Fentanyl-Related Substances."
Memorandum from Chairman Pallone to the Subcommittee on Health
Opening Statement from Chairman Pallone as prepared for delivery
Opening Statement from Subcommittee Chairwoman Eshoo as prepared for delivery
Kemp L. Chester
Executive Office of the President
Office of National Drug Control Policy
Louis J. Milione
Principal Deputy Administrator
U.S. Drug Enforcement Administration
Lisa O. Monaco
Deputy Attorney General
U.S. Department of Justice
Douglas Throckmorton, M.D.
Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Nora D. Volkow, M.D.
Director, National Institute on Drug Abuse
National Institutes of Health